ERS

aTyr Pharma Announces Second Quarter 2023 Results and Provides Corporate Update

Retrieved on: 
Wednesday, August 9, 2023
International, Prevalence, Small RNA, Marketing, European Medicines Agency, Clinical trial, ILD, Medicine, Sarcoidosis, Research, Scleroderma, ERS, Committee, EMA, ATyr Pharma, Investment, Patient, SAN, European Respiratory Society, CEST, Diagnosis, Systemic scleroderma, International Congress on Tuberculosis, European Commission, Safety, Disease, D, Payment card, Pharmaceutical industry, EU

SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or the “Company”), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced second quarter 2023 results and provided a corporate update.

Key Points: 
  • Phase 2 EFZO-CONNECT™ study of efzofitimod in SSc-ILD expected to initiate in the third quarter of 2023.
  • Ended the second quarter of 2023 with $112.0 million in cash, cash equivalents and investments.
  • SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or the “Company”), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced second quarter 2023 results and provided a corporate update.
  • G&A Expenses: General and administrative expenses were $3.7 million for the second quarter of 2023.

Aidin Partners with Hospitals and Post-Acute Providers to Enhance Patient Care Coordination Throughout Central Florida

Retrieved on: 
Tuesday, August 8, 2023
Communication, Partnership, Aidin (name), NBC, Organization, Hospital, Patient, Length of stay, Heel, HHA, ERS, Case management, Growth, LOS, Transport, Health, SNF, Nursing, Central Florida

TAMPA, Fla., Aug. 8, 2023 /PRNewswire-PRWeb/ -- Aidin, a leading healthcare technology company, is proud to expand into Central Florida through its partnership with a premier not-for-profit healthcare system and post-acute providers. This supports Aidin's continued growth to enhance the experience for patients, hospital teams, and the providers supporting the communities after patients leave the hospital. The partnership is expected to improve patient care coordination, reduce readmissions, shorten length of stay (LOS), and ultimately enhance overall patient outcomes by focusing on referrals, authorizations, and transportation from in-patient care units and emergency rooms (ERs).

Key Points: 
  • The partnership is expected to improve patient care coordination, reduce readmissions, shorten length of stay (LOS), and ultimately enhance overall patient outcomes by focusing on referrals, authorizations, and transportation from in-patient care units and emergency rooms (ERs).
  • Hundreds of post-acute providers in the Tampa-St. Petersburg area joined Aidin last week to celebrate and kick off onboarding the Aidin platform.
  • With Aidin's streamlined case management and post-acute pre-cert and authorization workflows, patients throughout Central Florida will benefit from higher quality of care, and the hospitals leveraging Aidin will also reduce operational costs.
  • Aidin launches in Central Florida in September 2023 across 20 major hospitals and facilities, as well as thousands of community care providers.

Redefining Green Transportation: New Federal Bill Boosts Wireless EV Charging Program

Retrieved on: 
Monday, August 7, 2023
Ford Motor Company, Michigan Department of Transportation, Pressure, Greenhouse, Partnership, Legislation, EV, U.S. Department of Defense Strategy for Operating in Cyberspace, Assembly, Infrastructure, Anxiety, Airport, DTE Energy, GHG, California State Assembly districts, ERS, EVS, Inductive charging, MDOT, Wireless, DOT, AAPA, TASE, Electric Road, Fireworks, Mobile phone, Transport, Swedish Transport Administration electric road program, Atlantic Ocean

Representative Haley Stevens (D-MI) introduced the Wireless Electric Vehicle Charging Grant Program Act of 2023 , to expand Wireless EV Charging Programs at the federal level.

Key Points: 
  • Representative Haley Stevens (D-MI) introduced the Wireless Electric Vehicle Charging Grant Program Act of 2023 , to expand Wireless EV Charging Programs at the federal level.
  • The new law would create a dedicated grant program in the U.S. Department of Transportation (DOT), providing funding for Wireless EV Charging projects.
  • This includes $250 million in grants for Wireless EV Charging initiatives such as roads, parking lots, bus routes, airports, as well as coastal and inland ports.
  • The Wireless EV Charging bill is rooted in the Michigan Department of Transportation's (MDOT) 2021-2022 pilot program that enabled the first public wireless EV charging road in the U.S. -  a pioneering project deploying Electreon's proprietary wireless charging technology , a collaborative endeavor between multiple stakeholders including Electreon, MDOT, Ford Motor Co., DTE Energy Co. OFME, Next Energy, Jacobs, Michigan Central, and the city of Detroit, among others.

ERS Genomics & Transomic Technologies enter into CRISPR/Cas9 Licensing Agreement

Retrieved on: 
Thursday, August 3, 2023
Nobel Prize, CRISPR, Genomics, Gene editing, Cas9, Research, ERS, Patent, Collection, Drug discovery, Transom (nautical), Pharmaceutical industry, Antibiotics

DUBLIN and HUNTSVILLE, Ala., Aug. 3, 2023 /PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Transomic Technologies ('Transomic'). This is a non-exclusive licensing agreement granting Transomic access to the foundational ERS CRISPR/Cas9 patent portfolio. 

Key Points: 
  • DUBLIN and HUNTSVILLE, Ala., Aug. 3, 2023 /PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Transomic Technologies ('Transomic').
  • This is a non-exclusive licensing agreement granting Transomic access to the foundational ERS CRISPR/Cas9 patent portfolio.
  • Dr. Emmanuelle Charpentier, founder of ERS Genomics, received the 2020 Nobel Prize for the discovery of CRISPR/Cas9.
  • Eric Rhodes, CEO, ERS Genomics, was equally enthusiastic about the new agreement: "Transomic has established an impressive reputation for providing scientists with accessible and innovative solutions.

ERS Genomics & Transomic Technologies enter into CRISPR/Cas9 Licensing Agreement

Retrieved on: 
Thursday, August 3, 2023
Nobel Prize, CRISPR, Genomics, Gene editing, Cas9, Research, ERS, Patent, Collection, Drug discovery, Transom (nautical), Pharmaceutical industry

DUBLIN and HUNTSVILLE, Ala., Aug. 3, 2023 /PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Transomic Technologies ('Transomic'). This is a non-exclusive licensing agreement granting Transomic access to the foundational ERS CRISPR/Cas9 patent portfolio. 

Key Points: 
  • DUBLIN and HUNTSVILLE, Ala., Aug. 3, 2023 /PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Transomic Technologies ('Transomic').
  • This is a non-exclusive licensing agreement granting Transomic access to the foundational ERS CRISPR/Cas9 patent portfolio.
  • Dr. Emmanuelle Charpentier, founder of ERS Genomics, received the 2020 Nobel Prize for the discovery of CRISPR/Cas9.
  • We are very excited to be able to continue to expand our CRISPR/Cas9 research tool business by licensing this important patent portfolio from ERS genomics."

Dr. Luke Lathrop and Stacy Lathrop of Roswell Launch First Drive-Thru Medical Clinic in Georgia; SmartMED Drive-Thru is Revolutionizing the Medical Industry and the Patient Experience

Retrieved on: 
Friday, July 28, 2023
Drive-through, Bronchitis, Genetics, Parent, Infection, Influenza, Lower respiratory tract infection, RSV, Patient, ERS, Toxicology, Diagnosis, Social media, Strep, Hospital, Vaccine

ATLANTA, July 28, 2023 /PRNewswire/ -- SmartMED Drive-Thru , a one-of-a-kind, drive-thru medical clinic in Roswell, GA is transforming how medical care is delivered and received.

Key Points: 
  • ATLANTA, July 28, 2023 /PRNewswire/ -- SmartMED Drive-Thru , a one-of-a-kind, drive-thru medical clinic in Roswell, GA is transforming how medical care is delivered and received.
  • Providing patients with quick, convenient, and compassionate care in the comfort of their own cars, SmartMED is changing medicine.
  • What started as a drive-thru Covid testing site quickly became a full-service medical practice by August of 2022.
  • Since then, all three generations have returned for treatment and now consider SmartMED their first stop when medical issues arise.

IPVideo's Sentry ERS Lockdown and Emergency Response System Earns Four Spaces4Learning 2023 New Product Awards

Retrieved on: 
Tuesday, July 25, 2023
BAY, ERS, Security, K-12, School, Student, Education, Platinum, Gold, Film industry, Nursing, Sentry

BAY SHORE, N.Y., July 25, 2023 /PRNewswire-PRWeb/ -- Sentry ERS, the leading lockdown and emergency response system for schools and campus environments, has won four Spaces4Learning 2023 New Product Awards. In both the K-12 and Higher Education Safety & Security categories of Classroom Security Devices and Emergency Communication (device), Sentry ERS earned Platinum and Gold honors respectively. The Spaces4Learning New Product Award program honors the outstanding product development achievements of manufacturers and suppliers whose products or services are considered to be particularly noteworthy in their ability to enhance the learning environment.

Key Points: 
  • Sentry ERS, IPVideo Corporation's leading lockdown and emergency response system for schools and campus environments, has won four Spaces4Learning 2023 New Product Awards.
  • BAY SHORE, N.Y., July 25, 2023 /PRNewswire-PRWeb/ -- Sentry ERS, the leading lockdown and emergency response system for schools and campus environments, has won four Spaces4Learning 2023 New Product Awards.
  • In both the K-12 and Higher Education Safety & Security categories of Classroom Security Devices and Emergency Communication (device), Sentry ERS earned Platinum and Gold honors respectively.
  • Sentry ERS consists of two devices, a base unit with a lockdown button that can initiate lockdown protocols for the entire facility and a dedicated Sentry ERS QuickCom.

U.S. FDA accepts supplemental New Drug Application for OFEV® (nintedanib) for children and adolescents aged 6-17 years old with fibrosing interstitial lung disease

Retrieved on: 
Tuesday, July 25, 2023
European Respiratory Society, Medical Affairs Bureau, Diarrhea, New Drug Application, ILD, ATSF, American Journal of Respiratory and Critical Care Medicine, Children's Hospital, Children's Hospital Colorado, ERS, Pulmonary fibrosis, Boehringer Ingelheim, Shanda, ERJ, Patient, FCCP, Diagnosis, Ageing, European Respiratory Journal, FDA, International Congress on Tuberculosis, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, III, Food, Safety, Pharmaceutical industry

"If approved, OFEV would be the first and only approved treatment for children and adolescents aged 6-17 years old with fibrosing interstitial lung disease, representing an important step forward for these patients."

Key Points: 
  • "If approved, OFEV would be the first and only approved treatment for children and adolescents aged 6-17 years old with fibrosing interstitial lung disease, representing an important step forward for these patients."
  • In children and adolescents with fibrosing ILD, a weight-based dosing regimen resulted in exposure of nintedanib similar to adults and with a similar safety profile.
  • The most common adverse event associated with nintedanib compared to placebo in the InPedILD trial was diarrhea.
  • The complete results were published in the European Respiratory Journal (ERJ) and presented at the European Respiratory Society (ERS) International Congress in September 2022.

Electreon, Together with VINCI, Wins Its First Tender in France, Marking a Significant Milestone in Decarbonizing Road Transport; Positioning France Alongside Sweden, Germany, Italy, Norway and the U.S. with its First Wireless Electric Road for Electric V

Retrieved on: 
Wednesday, July 12, 2023
Carbon, Gustave Eiffel University, ERS, EVS, Serial Attached SCSI, Nickel, TASE, VINCI, CO2, Architecture, A10, Mot, Cobalt, Lithium, Software, Rail transport, Renewable energy, Swedish Transport Administration electric road program

Bpifrance, together with the relevant French Ministries, selected Electreon and its consortium partners for the project as part of its strategy to promote decarbonized mobility.

Key Points: 
  • Bpifrance, together with the relevant French Ministries, selected Electreon and its consortium partners for the project as part of its strategy to promote decarbonized mobility.
  • The consortium is led by VINCI Autoroutes with several additional partners to Electreon - VINCI Construction, Hutchinson, and the Gustave Eiffel University.
  • Electreon will deploy both a two-kilometer dynamic wireless charging road and a stationary wireless charging station.
  • "We are honored that Electreon has been selected as the on-the-go wireless charging technology for France's first ERS deployment.

Feedback Digest from Global Consultation on Ecosystem Restoration Standard

Retrieved on: 
Friday, June 30, 2023
Central Waqf Council, Kathleen Funder, C11 (C standard revision), Standard, ERS, Organization, Documentation, Non-governmental organization, Project, TAB, Biodiversity, Risk management

PARIS, June 30, 2023 (GLOBE NEWSWIRE) -- Ecosystem Restoration Standard (ERS) released a summary of the feedback following the successful completion of its public consultation.

Key Points: 
  • PARIS, June 30, 2023 (GLOBE NEWSWIRE) -- Ecosystem Restoration Standard (ERS) released a summary of the feedback following the successful completion of its public consultation.
  • Launched on March 21st, ERS public consultation has exceeded expectations, drawing substantial participation from 554 organizations around the globe.
  • “We’re thrilled by the response to the public consultation.
  • Participate in the official launch of the Ecosystem Restoration Standard in September.